Author

Janneke D.M. Molkenboer‐Kuenen

Observed names: J Molkenboer, J. D. M. Molkenboer-Kuenen, J. Molkenboer, J. Molkenboer-Kuenen, J.D.M. Molkenboer-Kuenen, J.D.M. Molkenboer‐Kuenen, JDM Molkenboer-Kuenen, Janneke D M Molkenboer-Kuenen, Janneke D Molkenboer-Kuenen, Janneke D. M. Molkenboer-Kuenen, Janneke D. M. Molkenboer-kuenen, Janneke D. Molkenboer-Kuenen, Janneke D.M. Molkenboer, Janneke D.M. Molkenboer-Kuenen, Janneke D.m. Molkenboer-Kuenen, Janneke DM Molkenboer-Kuenen, Janneke Molkenboer, Janneke Molkenboer-Kuenen, Janneke Molkenboer‐Kuenen, Molkenboer-Kuenen, J.D.M., Molkenboer-Kuenen, Janneke D. M.

Institutions: Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Health Sciences

Observed institutions: University of Fukui, Nationwide Children's Hospital, Radboud University Nijmegen, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Radboud Institute for Health Sciences, Abigail Wexner Research Institute, University of Amsterdam

ORCID: 0009-0007-0879-5660

Observed ORCID: 0009-0007-0879-5660

OpenAlex ID: A5038166330

Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

2015 · Sandra Heskamp, Willemijn Hobo, et al. · Cancer Research · 234

Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent

2016 · Kristell L.S. Chatalic, Sandra Heskamp, et al. · Theranostics · 124

The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier

2019 · R. M. de Kruijff, R. Raavé, et al. · Scientific Reports · 94

ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model

2010 · Sandra Heskamp, Hanneke W.M. van Laarhoven, et al. · Journal of Nuclear Medicine · 93

Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head‐and‐neck squamous cell carcinoma model

2010 · Bianca A.W. Hoeben, Janneke D.M. Molkenboer‐Kuenen, et al. · International Journal of Cancer · 58

213 Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts

2017 · Julie Nonnekens, Kristell L.S. Chatalic, et al. · Cancer Biotherapy and Radiopharmaceuticals · 57

Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodies

2013 · Sandra Heskamp, Otto C. Boerman, et al. · International Journal of Cancer · 54

Differential loading methods for BMP-2 within injectable calcium phosphate cement

2012 · Floor C.J. van de Watering, Janneke D.M. Molkenboer-Kuenen, et al. · Journal of Controlled Release · 54

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

2017 · Sandra Heskamp, Reinier Hernandez, et al. · Journal of Nuclear Medicine · 51

Renal cell carcinoma–associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen‐dr molecules to CD4+ T lymphocytes

2002 · Joost L.M. Vissers, I. Jolanda M. de Vries, et al. · International Journal of Cancer · 47

Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507

2011 · Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, et al. · Clinical Cancer Research · 43

Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody

2011 · Catharina M. van Rij, Robert M. Sharkey, et al. · Journal of Nuclear Medicine · 42

Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.

2005 · Frank G van Schaijk, Egbert Oosterwijk, et al. · PubMed · 42

Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients

2015 · Sandra Heskamp, Otto C. Boerman, et al. · PLoS ONE · 40

Optimization of IGF-1R SPECT/CT Imaging Using 111In-Labeled F(ab′)2 and Fab Fragments of the Monoclonal Antibody R1507

2012 · Sandra Heskamp, Hanneke W. M. van Laarhoven, et al. · Molecular Pharmaceutics · 39

PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2018 · Sandra Heskamp, Peter J. Wierstra, et al. · Cancer Immunology Research · 38

Targeting of adenovirus to human renal cell carcinoma cells

2003 · Wim Jongmans, Kelly van den Oudenalder, et al. · Urology · 24

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma

2024 · Simone C. Kleinendorst, Egbert Oosterwijk, et al. · Theranostics · 22

Characterization of Site-Specifically Conjugated Monomethyl Auristatin E– and Duocarmycin-Based Anti-PSMA Antibody–Drug Conjugates for Treatment of PSMA-Expressing Tumors

2017 · Susanne Lütje, Danny Gerrits, et al. · Journal of Nuclear Medicine · 22

Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy

2008 · Kees Hendricksen, Janneke Molkenboer‐Kuenen, et al. · British Journal of Urology · 22

Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice

2019 · Robin M. de Kruijff, René Raavé, et al. · Pharmaceutics · 20

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT

2020 · D. Lobeek, M. Rijpkema, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 18

PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases

2022 · Gerwin G. W. Sandker, Gosse Adema, et al. · Frontiers in Immunology · 11

A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT

2019 · Daphne Lobeek, Frédérique C.M. Bouwman, et al. · Journal of Nuclear Medicine · 11

Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents

2022 · Iris M. Hagemans, Peter J. Wierstra, et al. · Journal of Nanobiotechnology · 10

Works count: 93

Citation count: 1,330

H-index: 20

I10-index: 26